Chia, a large annotated corpus of clinical trial eligibility criteria

Fabrício Kury1, Alex Butler1, Chi Yuan1

  • 1Columbia University in the City of New York, New York, NY, United States.

Scientific Data
|August 29, 2020
PubMed

Insights

We introduce Chia, a large annotated corpus for clinical trial eligibility criteria. This dataset aids in developing advanced methods for extracting crucial patient information from trial data.

Area of Science:

  • Natural Language Processing
  • Clinical Informatics
  • Biomedical Data Science

Background:

  • Clinical trial eligibility criteria are complex and often unstructured.
  • Efficiently extracting this information is crucial for trial recruitment and analysis.
  • Existing methods for processing eligibility criteria are limited.

Purpose of the Study:

  • To present Chia, a novel, large annotated corpus of patient eligibility criteria.
  • To provide a benchmark dataset for developing and testing information extraction methods.
  • To facilitate the transformation of eligibility criteria into computable formats.

Main Methods:

  • Extracted eligibility criteria from 1,000 interventional, Phase IV clinical trials registered in ClinicalTrials.gov.
  • Annotated 12,409 eligibility criteria, identifying 41,487 entities and 25,017 relationships.
  • Represented each criterion as a directed acyclic graph for potential Boolean logic transformation.

Main Results:

  • Developed Chia, a comprehensive corpus of annotated clinical trial eligibility criteria.
  • The corpus contains 15 entity types and 12 relationship types.
  • Eligibility criteria are structured as directed acyclic graphs.

Conclusions:

  • Chia serves as a valuable resource for advancing information extraction from clinical trial data.
  • Enables the development of machine learning, rule-based, and hybrid approaches.
  • Facilitates the creation of database queries from free-text eligibility criteria.

Related Concept Videos

Clinical Trials: Overview01:11

Clinical Trials: Overview

Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
4.4K
Clinical Trials01:16

Clinical Trials

Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.0K
Hazard Ratio01:12

Hazard Ratio

The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
445
Classification of Illness01:17

Classification of Illness

The meaning of illness is individualized to each person who experiences an alteration in health. In contrast, disease is a medical term indicating a pathological change in the structure and function of the body or mind. It is a condition that has specific symptoms and boundaries.
An illness is a response to a disease in which the person's level of functioning is changed compared with a previous level. The general classification of illness includes acute and chronic.
Acute illness is severe...
8.4K
Cardiovascular Drugs: Classification based on Therapeutic Indications01:18

Cardiovascular Drugs: Classification based on Therapeutic Indications

Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
3.8K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
302